157 related articles for article (PubMed ID: 6138600)
1. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis.
Chang TM; Barre P
Lancet; 1983 Nov; 2(8358):1051-3. PubMed ID: 6138600
[TBL] [Abstract][Full Text] [Related]
2. Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers.
Aarseth HP; Ganss R
Nephrol Dial Transplant; 1990; 5(11):942-4. PubMed ID: 2127830
[TBL] [Abstract][Full Text] [Related]
3. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
Weiss LG; Danielson BG; Fellström B; Wikström B
Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
Allain P; Chaleil D; Mauras Y; Beaudeau G; Varin MC; Poignet JL; Ciancioni C; Ang KS; Cam G; Simon P
Clin Chim Acta; 1987 Dec; 170(2-3):331-8. PubMed ID: 3436066
[TBL] [Abstract][Full Text] [Related]
5. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
Graf H; Stummvoll HK; Meisinger V
Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
[TBL] [Abstract][Full Text] [Related]
6. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis.
Vasilakakis DM; D'Haese PC; Lamberts LV; Lemoniatou E; Digenis PN; De Broe ME
Kidney Int; 1992 May; 41(5):1400-7. PubMed ID: 1614055
[TBL] [Abstract][Full Text] [Related]
7. Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.
McCarthy JT; Milliner DS; Schmidt DF; Schniepp BJ; Kurtz SB; Johnson WJ
Kidney Int; 1988 Dec; 34(6):804-8. PubMed ID: 3210542
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities of using hemoperfusion in the treatment of chronic kidney insufficiency].
Falkenhagen D; Holtz M; Schmidt R; Osten B; Klinkmann H
Z Urol Nephrol; 1979 Jan; 72(1):9-16. PubMed ID: 371244
[TBL] [Abstract][Full Text] [Related]
9. Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.
Ciancioni C; Poignet JL; Naret C; Delons S; Mauras Y; Allain P; Man NK
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():469-73. PubMed ID: 3991542
[TBL] [Abstract][Full Text] [Related]
10. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
Chang TM
Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
[TBL] [Abstract][Full Text] [Related]
11. Desferrioxamine induced aluminium removal in haemodialysis.
Bonal J; Montoliu J; Löpez Pedret J; Bergadä E; Andrew L; Bachs M; Revert L
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():366-70. PubMed ID: 3991524
[TBL] [Abstract][Full Text] [Related]
12. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?
Higgins RM; Hearing S; Goldsmith DJ; Keevil B; Venning MC; Ackrill P
Postgrad Med J; 1995 Apr; 71(834):224-6. PubMed ID: 7784283
[TBL] [Abstract][Full Text] [Related]
13. Haemoperfusion in the management of end-stage renal disease.
Winchester JF
Life Support Syst; 1984; 2(2):107-11. PubMed ID: 6384670
[TBL] [Abstract][Full Text] [Related]
14. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
Simon P
Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038
[No Abstract] [Full Text] [Related]
15. Haemodialysis with charcoal haemoperfusion.
Winchester JF; Apiliga MT; Mackay JM; Kennedy AC
Proc Eur Dial Transplant Assoc; 1976; 12():526-33. PubMed ID: 935131
[TBL] [Abstract][Full Text] [Related]
16. Coated charcoal haemoperfusion.
Chang TM
Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
[TBL] [Abstract][Full Text] [Related]
17. Copper removal from renal patients using desferrioxamine chelation to reduce aluminium overload.
Hewitt CD; Garstang FM; O'Hara M; Metcalfe PJ; Ackrill P; Day JP
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():431-4. PubMed ID: 3776602
[No Abstract] [Full Text] [Related]
18. Effect of desferrioxamine on aluminum kinetics during hemodialysis.
Stummvoll HK; Graf H; Meisinger V
Miner Electrolyte Metab; 1984; 10(4):263-6. PubMed ID: 6749073
[TBL] [Abstract][Full Text] [Related]
19. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
Delmez J; Weerts C; Lewis-Finch J; Windus D; Slatopolsky E
Am J Kidney Dis; 1989 Apr; 13(4):308-11. PubMed ID: 2705449
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
Verpooten GA; D'Haese PC; Boelaert JR; Becaus I; Lamberts LV; De Broe ME
Nephrol Dial Transplant; 1992; 7(9):931-8. PubMed ID: 1328941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
